Navigation Links
CellCyte Genetics Corporation: Seattle Times Erroneously Reports That CellCyte 'Closes'
Date:12/29/2008

LUDE ANY STATEMENTS REGARDING BELIEFS, PLANS, EXPECTATIONS OR INTENTIONS REGARDING THE FUTURE. EXCEPT FOR THE HISTORICAL INFORMATION PRESENTED HEREIN, MATTERS DISCUSSED IN THIS NEWS RELEASE CONTAIN FORWARD-LOOKING STATEMENTS THAT ARE SUBJECT TO CERTAIN RISKS AND UNCERTAINTIES THAT COULD CAUSE ACTUAL RESULTS TO DIFFER MATERIALLY FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY SUCH STATEMENTS. STATEMENTS THAT ARE NOT HISTORICAL FACTS, INCLUDING STATEMENTS THAT ARE PRECEDED BY, FOLLOWED BY, OR THAT INCLUDE SUCH WORDS AS "ESTIMATE," "ANTICIPATE," "BELIEVE," "PLAN" OR "EXPECT" OR SIMILAR STATEMENTS ARE FORWARD- LOOKING STATEMENTS. RISKS AND UNCERTAINTIES FOR THE COMPANY INCLUDE, BUT ARE NOT LIMITED TO, THE RISKS ASSOCIATED WITH THE RESEARCH AND DEVELOPMENT OF THE COMPANY'S THERAPEUTIC PIPELINE, INCLUDING RISKS RELATED TO EXECUTING PARTNERSHIPS TO PERFORM THE ADDITIONAL RESEARCH AND THE RESULTS OF ANY ADDITIONAL RESEARCH PERFORMED ON THE RECEPTOR BLOCKING COMPOUNDS, AS WELL AS RISKS ASSOCIATED WITH THE DEVICE DIVISION, INCLUDING RISKS RELATED TO SUPPLY AGREEMENTS FOR THE BIOREACTOR DEVICE . OTHER RISKS INCLUDE RISKS ASSOCIATED WITH THE REGULATORY APPROVAL PROCESS, COMPETITIVE PRODUCTS AND COMPANIES AND THE COMPANY'S ABILITY AND LEVEL OF SUPPORT FOR ITS RESEARCH AND DEVELOPMENT ACTIVITIES. THERE CAN BE NO ASSURANCE THAT THE COMPANY'S DEVELOPMENT EFFORTS WILL SUCCEED AND THE COMPANY WILL ULTIMATELY ACHIEVE COMMERCIAL SUCCESS. THESE FORWARD-LOOKING STATEMENTS ARE MADE AS OF THE DATE OF THIS NEWS RELEASE, AND THE COMPANY ASSUMES NO OBLIGATION TO UPDATE THE FORWARD-LOOKING STATEMENTS, OR TO UPDATE THE REASONS WHY ACTUAL RESULTS COULD DIFFER FROM THOSE PROJECTED IN THE FORWARD-LOOKING STATEMENTS. ALTHOUGH THE COMPANY BELIEVES THAT THE BELIEFS, PLANS, EXPECTATIONS, AND INTENTIONS CONTAINED IN THIS NEWS RELEASE ARE REASONABLE, THERE CAN BE NO ASSURANCE THOSE BELIEFS, PLANS, EXPECTATIONS, OR INTENTIONS WILL PROVE TO BE ACCURATE. INVESTORS SHOULD CONSID
'/>"/>
SOURCE CellCyte Genetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. CellCyte Genetics Corp. Appoints Tony Colasin as Director of Business Development
2. Beta Release of a New Genetics Website- ItRunsInMyFamily.com
3. PTSD Risk Rooted in Stress and Genetics
4. Texas and North Carolina Students Tackle Lifesaving Research in Chemistry and Genetics, Taking Home the Grand Prize at Nations Premier High School Science Competition
5. Understanding donor-recipient genetics could decrease early kidney transplant complications
6. Lung Cancer Genetics Different in Black Patients: Study
7. Genetics of aging and cancer resistance
8. Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery
9. New technique to study the genetics of breast cancer
10. Know the Myths and Facts About Family Health History: American College of Medical Genetics
11. Interleukin Genetics Announces Conference Call and Webcast to Discuss Third Quarter 2008 Business Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... ... July 28, 2015 , ... Conducting Advanced Root ... to Improve the Quality of Investigations , **Presented by FDAnews and Learning Plus**, ... CAPAs have been the #1 reason for 483 observations since 1997! , The ...
(Date:7/27/2015)... NY (PRWEB) , ... July 28, 2015 , ... ... a 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She is ... and over 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... science of the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today announced ... of Neurology (AAN). The FSHD care guideline is published today. , This ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... North Central ... 2015. , The center invites all those prospective joint-replacement patients, along with their ... Thursday of each month, with Monday classes (Aug 6, Sept 8 [Tue due to ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... is a professional and in-depth research report. The report provides basic information ... market analysis etc. This report covers the global (US, Europe, Japan etc) ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3
... Address FDA,s Next Big Challenge, Is the Food ... Devices to Physicians and the Public?, WASHINGTON, Nov. ... device that repairs damaged cells and treats cancer through,electromagnetic ... its apparent connection to patient injuries and death. However,on ...
... - The Westaim Corporation,announced today that it has reached ... in Canadian third party asset-backed commercial paper (ABCP) with,a ... $6.0 million.,Westaim retains the right to receive additional proceeds ... six months; in such event, Westaim,will receive 50 per ...
... (Nasdaq: FLEX ),today announced that it will report ... earnings conference call, hosted by Flextronics,s senior,management, will be ... results,of the Company for its third quarter ended December ... via the Internet and may be,accessed by logging on ...
... may be undertreated compared to white patients, research suggests , ... likely than white women to suffer severe pain linked to ... than 1,100 patients in 19 countries. , The women -- ... given a pain test called the Brief Pain Inventory repeatedly ...
... Kocot and Robert,Seidman Headline Agenda at FDA/CMS Summit ... has,progressed beyond a topic of industry insider buzz ... and private payers. Value isn,t a new,concept in ... for buying and,selling biopharmaceuticals? How is value calculated, ...
... Nov. 26 Pharmasset, Inc.,(Nasdaq: VRUS ) ... & Sales, responsible for coordinating the global product ... Higgins, who,has served as a consultant to Pharmasset ... Virology at Hoffmann-LaRoche, Inc. His areas,of expertise include ...
Cached Medicine News:Health News:Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information 2Health News:Westaim reduces ABCP exposure 2Health News:Flextronics to Report Third Quarter Results 2Health News:Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace 2Health News:Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace 3Health News:Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales 2Health News:Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales 3
(Date:7/27/2015)... , July 20, 2015 Research ... addition of the "Key Pharma News Issue" ... This acquisition bolsters Gilead Sciences, burgeoning oncology pipeline ... will make further oncology deals in 2015, with ... of 2016. Key Pharma News ...
(Date:7/27/2015)... Belgium , July 27, 2015 /PRNewswire/ ... life sciences company focused on developing blood-based diagnostic tests ... conditions, today announced that it has engaged the services ... Specimen Solutions, Inc. (GSS), to support initial U.S. market ... Under the agreement, GSS will target ...
(Date:7/27/2015)... , July 27, 2015 Syneron ... ) , a global market leader in the aesthetic ... Korean Ministry of Food and Drug Safety (MFDS) regulatory ... clearance, the Company can fulfill PicoWay orders from its ... Korea anticipated later in the third quarter 2015. ...
Breaking Medicine Technology:Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4
... Interventional Radiology Treatment Relieves Pain From Herniated Disks; ... but With Fewer Complications, Shorter Recovery TimeSAN DIEGO, ... treatment--that safely and effectively uses oxygen/ozone to relieve ... the United States in the next few years, ...
... Minimally Invasive "Lumpectomy" -- as Effective as Surgery -- ... Mapping Biopsy Changed Patients, Management 70 Percent of the ... -- a minimally invasive interventional radiology treatment for prostate ... diseased tumors and can be considered a first-line treatment ...
Cached Medicine Technology:Oh, My Aching Back: Give Me a Shot of Ozone 2Oh, My Aching Back: Give Me a Shot of Ozone 3Oh, My Aching Back: Give Me a Shot of Ozone 4Oh, My Aching Back: Give Me a Shot of Ozone 5Freezing Prostate Cancer Does a Man's Body Good 2Freezing Prostate Cancer Does a Man's Body Good 3Freezing Prostate Cancer Does a Man's Body Good 4Freezing Prostate Cancer Does a Man's Body Good 5Freezing Prostate Cancer Does a Man's Body Good 6Freezing Prostate Cancer Does a Man's Body Good 7
Inquire...
Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....
BD Vacutainer® Fluoride Tubes - Glass...
VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
Medicine Products: